Sappikivienestettä

Sappikivienestettä, also known as ursodeoxycholic acid (UDCA) or chenodeoxycholic acid (CDCA), is a medication used to dissolve certain types of gallstones. These medications are bile acids that are naturally found in the body in smaller amounts. They work by reducing the amount of cholesterol secreted by the liver into bile and by increasing the solubility of cholesterol in bile, which can help break down cholesterol-rich gallstones.

Sappikivienestettä is typically prescribed for patients who have cholesterol gallstones that are not visible on an X-ray, meaning they are primarily composed of cholesterol. It is generally not effective for gallstones that contain calcium or are calcified. The medication is taken orally, usually in capsule or tablet form. The duration of treatment can vary significantly, often ranging from several months to over a year, depending on the size and number of gallstones.

The effectiveness of sappikivienestettä can vary among individuals. Some patients experience complete dissolution of their gallstones, while others may see only a reduction in size or no change at all. It is important to note that even after gallstones have dissolved, there is a possibility of them reforming. Therefore, ongoing monitoring by a healthcare professional is often recommended. Common side effects are generally mild and may include diarrhea, nausea, and abdominal discomfort. In rare cases, more serious side effects can occur. This treatment is not suitable for everyone, and a doctor will determine if it is the appropriate option based on the patient's medical history and the characteristics of their gallstones.